These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16223866)

  • 41. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
    Kiaris H; Schally AV; Sun B; Armatis P; Groot K
    Oncogene; 1999 Nov; 18(50):7168-73. PubMed ID: 10597318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    Wu JM; Hoang DO; Feldman RI
    Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localisation of mRNA and co-expression and molecular forms of GRP gene products in endocrine cells of fetal human lung.
    Bhatnagar M; Springall DR; Ghatei MA; Burnet PW; Hamid Q; Giaid A; Ibrahim NB; Cuttitta F; Spindel ER; Penketh R
    Histochemistry; 1988; 90(4):299-307. PubMed ID: 3068217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on multiple forms of proGRP in serum from small cell lung cancer patients.
    Nordlund MS; Warren DJ; Laerdahl JK; Paus E
    Tumour Biol; 2009; 30(5-6):265-75. PubMed ID: 19907206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gastrin-releasing peptide and cancer.
    Patel O; Shulkes A; Baldwin GS
    Biochim Biophys Acta; 2006 Aug; 1766(1):23-41. PubMed ID: 16490321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pro-Gastrin Releasing Peptide: A New Serum Marker for Endometrioid Adenocarcinoma.
    Kiseli M; Caglar GS; Yarci Gursoy A; Tasci T; Candar T; Akincioglu E; Pabuccu EG; Boran N; Tulunay G; Umudum H
    Gynecol Obstet Invest; 2018; 83(6):540-545. PubMed ID: 29898448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High concentration of a gastrin releasing peptide-like immunoreactive substance in pregnant human milk.
    Takeyama M; Kondo K; Takayama F; Kondo R; Murata H; Miyakawa I
    Biochem Biophys Res Commun; 1991 Apr; 176(2):931-7. PubMed ID: 2025302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-related changes of serum progastrin-releasing peptide levels during childhood.
    Adachi N; Aoyagi K; Saito M; Matsuda I; Yamaguchi K
    Acta Paediatr Jpn; 1997 Jun; 39(3):336-8. PubMed ID: 9241895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stability of pro-gastrin-releasing peptide in serum versus plasma.
    Yoshimura T; Fujita K; Kawakami S; Takeda K; Chan S; Beligere G; Dowell B
    Tumour Biol; 2008; 29(4):224-30. PubMed ID: 18781094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pregnant ovine endometrium constitutively expresses and secretes a highly stable bombesin-like peptide, which shares C-terminal sequence but differs structurally from gastrin-releasing peptide.
    Giraud A; Whitley J; Shulkes A; Parker L
    Biochim Biophys Acta; 1996 Sep; 1296(2):189-97. PubMed ID: 8814226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Posttranslational processing of endogenous and of baculovirus-expressed human gastrin-releasing peptide precursor.
    Lebacq-Verheyden AM; Kasprzyk PG; Raum MG; Van Wyke Coelingh K; Lebacq JA; Battey JF
    Mol Cell Biol; 1988 Aug; 8(8):3129-35. PubMed ID: 3211139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrin-releasing peptide: a potential growth factor expressed in human neuroblastoma tumors(1).
    Sebesta JA; Young A; Bullock J; Moore KH; Azarow K; Sawin RS
    Curr Surg; 2001 Jan; 58(1):86-89. PubMed ID: 11226544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number.
    Matkowskyj KA; Cox R; Jensen RT; Benya RV
    J Histochem Cytochem; 2003 Feb; 51(2):205-14. PubMed ID: 12533529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrin-releasing peptide: different forms, different functions.
    Ischia J; Patel O; Shulkes A; Baldwin GS
    Biofactors; 2009; 35(1):69-75. PubMed ID: 19319848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Biomimetic C-Terminal Extension Strategy for Photocaging Amidated Neuropeptides.
    Layden AE; Ma X; Johnson CA; He XJ; Buczynski SA; Banghart MR
    J Am Chem Soc; 2023 Sep; 145(36):19611-19621. PubMed ID: 37649440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer.
    Ueki K; Matsuo Y; Kishi N; Yoneyama M; Yoshida H; Sakamori Y; Ozasa H; Hirai T; Mizowaki T
    J Radiat Res; 2022 Jul; 63(4):636-645. PubMed ID: 35780299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic value of ProGRP for small cell lung cancer in different stages.
    Dong A; Zhang J; Chen X; Ren X; Zhang X
    J Thorac Dis; 2019 Apr; 11(4):1182-1189. PubMed ID: 31179060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.
    Wojcik E; Kulpa JK
    Lung Cancer (Auckl); 2017; 8():231-240. PubMed ID: 29238236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.
    Nakamura H; Nishimura T
    Surg Today; 2017 Sep; 47(9):1037-1059. PubMed ID: 28229299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.